Terkko Navigator / Alimentary Pharmacology & Therapeutics

Safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in hepatitis C genotype 1 patients including those with decompensated cirrhosis who failed prior treatment with simeprevir/sofosbuvir

Editorial: use of beta‐blockers and band ligation in preventing first and recurrent variceal bleeding—“real life” vs evidence‐based decisions. Authors’ reply

Letter: the role of direct‐acting anti‐virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus‐induced cirrhosis—Authors' reply

Proton pump inhibitor use and risk of hip fractures among community‐dwelling persons with Alzheimer's disease—a nested case‐control study

Systematic review: probiotics in the management of lower gastrointestinal symptoms– an updated evidence‐based international consensus

Quantification of the duodenal eosinophil content in adults: a necessary step for an evidence‐based diagnosis of duodenal eosinophilia

Editorial: diabetes, obesity and clinical inertia—the recipe for advanced NASH. Authors’ reply

Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)

Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

An expert consensus for the management of chronic hepatitis B in Asian Americans

Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance

Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross‐disease cohort study

Corrigendum

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses? Authors’ reply

Editorial: diabetes, obesity and clinical inertia—the recipe for advanced NASH

Editorial: use of beta‐blockers and of band ligation in preventing first and recurrent variceal bleeding—“real life” vs evidence‐based decisions

Editorial: first among Equals—not for either infliximab or adalimumab in Crohn's disease—yet

Issue Information

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study

Microvesicles in hepatic and peripheral vein can predict nonresponse to corticosteroid therapy in severe alcoholic hepatitis

Letter: the role of direct‐acting anti‐virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus‐induced cirrhosis

Systematic review: non A‐E, seronegative or indeterminate hepatitis; what is this deadly disease?

Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti‐tumour necrosis factor

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Bariatric surgery is associated with increased risk of new‐onset inflammatory bowel disease: case series and national database study

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Long‐term effect of medical treatment of diarrhoea in 377 patients with SeHCAT scan diagnosed bile acid malabsorption from 2003 to 2016; a retrospective study

Systematic review: the natural history of alpha‐1 antitrypsin deficiency, and associated liver disease

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014

Editorial: older‐onset inflammatory bowel disease—is it time to start looking beyond a number?

Letter: extensive intestinal metaplasia is associated with the presence of incomplete intestinal metaplasia subtype and could be an easier marker for high risk of gastric cancer

Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct‐acting anti‐viral therapy

Letter: extensive intestinal metaplasia is associated with the presence of incomplete intestinal metaplasia subtype and could be an easier marker for high risk of gastric cancer Authors' reply

Corrigendum

Editorial: NAFLD in Asia—clinical associations with advanced disease become clearer

Reliability of histologic assessment in patients with eosinophilic oesophagitis

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab—Authors' reply

Editorial: NAFLD in Asia—clinical associations with advanced disease become clearer. Authors' reply

Editorial: clinical trials in IBD—how much of a difference is enough?

Editorial: ulcerative colitis submucosal fibrosis and inflammation: more than just strictures

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation

Hepatitis C virus re‐treatment in the era of direct‐acting antivirals: projections in the USA

Symptom association probability does not reliably distinguish functional heartburn from reflux hypersensitivity

Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis